Physician
Sleep & Lungs LLC
Sleep & Lungs LLC was paid $448K by Medicaid between Jan 2018 and Dec 2024, across 46 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
33Billing provider infoSLEEP & LUNGS LLC
HAMPTON, VA 23666
HAMPTON, VA 23666
33aNPI1669902532assigned 06/14/2017
33bProvider typeSleep Medicine (Internal Medicine) Physician
28Total paid$448K
24GClaims52,388
24DCodes billed46
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Sleep Medicine (Internal Medicine) Physician providers in Virginia
Rank by total paid#2 of 7
Median peer was paid$98K
This provider vs. median4.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,641 | $24K | |
| 2019 | 8,237 | $80K | |
| 2020 | 6,078 | $74K | |
| 2021 | 7,119 | $79K | |
| 2022 | 8,097 | $74K | |
| 2023 | 10,736 | $64K | |
| 2024incomplete | 8,480 | $52K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 2,982 | 2,436 | $159K |
| 94726 | 13% | 2,015 | 1,736 | $59K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 12% | 750 | 628 | $55K |
| 94060 | 12% | 2,024 | 1,743 | $54K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 1,366 | 1,181 | $52K |
| 94729 | 10.0% | 1,414 | 1,207 | $45K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.4% | 96 | 88 | $6K |
| 95806 | 1.4% | 76 | 65 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 928 | 816 | $4K |
| 1036F | <1% | 3,989 | 3,273 | $2K | |
| 94375 | <1% | 1,938 | 1,706 | $2K | |
| 3023F | <1% | 1,325 | 1,026 | $2K |
34 more codes
| 1123F | <1% | 1,362 | $1K | |
| 99458 | <1% | 43 | $1K | |
| 99457 | <1% | 61 | $684.72 | |
| 99454 | <1% | 41 | $418.06 | |
| 94660 | <1% | 30 | $215.00 | |
| M1168 | Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period | <1% | 1,416 | $0.10 |
| M1171 | Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period | <1% | 1,371 | $0.09 |
| G0030 | Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user | <1% | 492 | $0.06 |
| M1174 | Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period | <1% | 748 | $0.05 |
| M1178 | Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., prior anaphylaxis due to the pneumococcal vaccine) | <1% | 556 | $0.05 |
| 4004F | <1% | 1,494 | $0.05 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 6,058 | $0.05 |
| M1177 | Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period | <1% | 461 | $0.04 |
| M1175 | Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine) | <1% | 387 | $0.03 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 3,906 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 2,424 | $0.00 |
| G8924 | Spirometry results documented (fev1/fvc < 70%) | 0% | 1,219 | $0.00 |
| G9521 | Total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months | 0% | 253 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 1,829 | $0.00 |
| G9699 | Long-acting inhaled bronchodilator not prescribed, reason not otherwise specified | 0% | 142 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 1,856 | $0.00 |
| G9432 | Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented | 0% | 857 | $0.00 |
| M1179 | Patient did not receive any pneumococcal conjugate or polysaccharide vaccine, on or after their 19th birthday and before or during measurement period | 0% | 336 | $0.00 |
| M1172 | Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine) | 0% | 233 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 33 | $0.00 |
| G9695 | Long-acting inhaled bronchodilator prescribed | 0% | 1,191 | $0.00 |
| 4040F | 0% | 97 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 2,278 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 1,860 | $0.00 |
| M1176 | Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period | 0% | 211 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 151 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 23 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 47 | $0.00 |
| G9991 | Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHIGURUPATI, NAGA (OWNER)